Bloomberg Businessweek Introducing IVF Disrupted: The Kindbody Story
Sep 21, 2025
Discover the rise and fall of Kindbody, a once-promising fertility chain that attracted major investments from celebrities. Delve into chilling accounts of clinical mishaps, including mislabeled and lost embryos that left patients reeling. The podcast highlights the urgency of navigating a fast-growing yet largely unregulated industry, illustrating both the allure and dangers of rapid expansion in healthcare. As demand for fertility treatments surges, Kindbody's story serves as a cautionary tale for aspiring startups.
AI Snips
Chapters
Transcript
Episode notes
Patients Drawn By Modern Clinic Appeal
- A woman began trying to get pregnant four years ago and felt the window closing as she aged.
- Patients were drawn to Kindbody's millennial-friendly clinics promising modern fertility care.
Growth Masked Clinical Risks
- Kindbody marketed itself as a tech-style disruptor in fertility, backed by venture capital and celebrities.
- That growth masked serious clinical failures and regulatory gaps in a fast-growing field.
Expectations Fueled By Image
- A co-worker praised Kindbody as "really amazing" based on its image and vibe.
- Many patients later felt betrayed when clinical care did not match the glossy promise.